Literature DB >> 12716798

Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women.

Barbara J Nicklas1, Brenda W J H Penninx, Alice S Ryan, Dora M Berman, Nicole A Lynch, Karen E Dennis.   

Abstract

OBJECTIVE: This study determined whether there is a critical level of visceral adipose tissue (VAT) associated with elevated coronary heart disease (CHD) risk factors in a cohort of women >45 years of age. RESEARCH DESIGN AND METHODS: Measurements of body composition (dual-energy X-ray absorptiometry), body fat distribution (computed tomography), fasting and 2-h postprandial (75-g) glucose concentrations, and fasting lipoprotein lipid and insulin concentrations were performed in 233 perimenopausal (9%) and postmenopausal women (age 59 +/- 6 years, 79% Caucasian, 16% on hormone replacement therapy).
RESULTS: Women in the lowest VAT quintile (< or =105 cm(2)) had higher concentrations of HDL and HDL(2) cholesterol, lower LDL/HDL cholesterol ratios and triglyceride concentrations, and lower fasting glucose and insulin concentrations than women in the remaining four quintiles (P values <0.05-0.001). Women in the second lowest VAT quintile (106-139 cm(2)) had higher HDL and HDL(2) cholesterol and lower LDL/HDL ratios than women with a VAT > or =163 cm(2) (P < 0.05). Logistic regression analyses showed that women with a VAT of 106-162 cm(2) are 2.5 times more likely to have a low HDL cholesterol (P < 0.05), while women with a VAT > or =163 cm(2) are 5.5 times more likely to have a low HDL cholesterol (P < 0.01) and approximately 4.0 times more likely to have a high LDL/HDL ratio (P < 0.05) compared with women with a VAT < or =105 cm(2). Women with a VAT > or =163 cm(2) are at a higher risk of having impaired glucose tolerance (P < 0.01).
CONCLUSIONS: A VAT > or =106 cm(2) is associated with an elevated risk, and a VAT > or =163 cm(2) with an even greater risk, for these metabolic CHD risk factors compared with women with a VAT < or =105 cm(2). These values may prove useful for defining "visceral obesity" and for identifying women most likely to benefit from preventative interventions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716798     DOI: 10.2337/diacare.26.5.1413

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  57 in total

1.  Visceral adiposity in young patients with coronary artery disease-a case control study.

Authors:  Blessan Varghese; Smrita Swamy; M A Srilakshmi; M J Santhosh; Gurappa G Shetty; Kiron Varghese; Chandrakant B Patil; Shamanna S Iyengar
Journal:  Indian Heart J       Date:  2012 May-Jun

2.  Silk and silkworm pupa peptides suppress adipogenesis in preadipocytes and fat accumulation in rats fed a high-fat diet.

Authors:  Sun Hee Lee; Dongsun Park; Goeun Yang; Dae-Kwon Bae; Yun-Hui Yang; Tae Kyun Kim; Dajeong Kim; Jangbeen Kyung; Sungho Yeon; Kyo Chul Koo; Jeong-Yong Lee; Seock-Yeon Hwang; Seong Soo Joo; Yun-Bae Kim
Journal:  Eur J Nutr       Date:  2011-12-13       Impact factor: 5.614

3.  Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study.

Authors:  Meredith C Foster; Shih-Jen Hwang; Joseph M Massaro; Udo Hoffmann; Ian H DeBoer; Sander J Robins; Ramachandran S Vasan; Caroline S Fox
Journal:  Obesity (Silver Spring)       Date:  2010-12-23       Impact factor: 5.002

4.  Visceral fat measured by DXA is associated with increased risk of non-spine fractures in nonobese elderly women: a population-based prospective cohort analysis from the São Paulo Ageing & Health (SPAH) Study.

Authors:  L G Machado; D S Domiciano; C P Figueiredo; V F Caparbo; L Takayama; R M Oliveira; J B Lopes; P R Menezes; R M R Pereira
Journal:  Osteoporos Int       Date:  2016-06-28       Impact factor: 4.507

5.  The effect of cardiorespiratory fitness on age-related lipids and lipoproteins.

Authors:  Yong-Moon Mark Park; Xuemei Sui; Junxiu Liu; Haiming Zhou; Peter F Kokkinos; Carl J Lavie; James W Hardin; Steven N Blair
Journal:  J Am Coll Cardiol       Date:  2015-05-19       Impact factor: 24.094

6.  Adiposity assessed by anthropometric measures has a similar or greater predictive ability than dual-energy X-ray absorptiometry measures for abdominal aortic calcification in community-dwelling older adults.

Authors:  Xianwen Shang; David Scott; Allison Hodge; Belal Khan; Nayab Khan; Dallas R English; Graham G Giles; Peter R Ebeling; Kerrie M Sanders
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-31       Impact factor: 2.357

7.  Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors.

Authors:  Tobin M Abraham; Alison Pedley; Joseph M Massaro; Udo Hoffmann; Caroline S Fox
Journal:  Circulation       Date:  2015-08-20       Impact factor: 29.690

8.  Visceral adipose tissue loss and insulin resistance 6 months after laparoscopic gastric banding surgery: a preliminary study.

Authors:  Joan F Carroll; Susan F Franks; Adam B Smith; David R Phelps
Journal:  Obes Surg       Date:  2008-07-29       Impact factor: 4.129

9.  Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes.

Authors:  Susan Sam; Steven Haffner; Michael H Davidson; Ralph B D'Agostino; Steven Feinstein; George Kondos; Alfonso Perez; Theodore Mazzone
Journal:  Diabetes Care       Date:  2009-07-10       Impact factor: 19.112

10.  Visceral and subcutaneous adiposity and brachial artery vasodilator function.

Authors:  Nisha I Parikh; Michelle J Keyes; Martin G Larson; Karla M Pou; Naomi M Hamburg; Joseph A Vita; Christopher J O'Donnell; Ramachandran S Vasan; Gary F Mitchell; Udo Hoffmann; Caroline S Fox; Emelia J Benjamin
Journal:  Obesity (Silver Spring)       Date:  2009-03-12       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.